CERTAIN INFORMATION CONCERNING THE PARTICIPANTS
Sarissa Capital Management LP (Sarissa Capital), together with the other participants named herein (collectively, Sarissa), intends to
file a preliminary proxy statement and accompanying proxy card with the Securities and Exchange Commission (SEC) to be used to solicit votes for the election of its slate of highly-qualified nominees as directors of Amarin Corporation
plc (NASDAQ: AMRN) (the Company), at a special meeting of shareholders of the Company. SARISSA STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY
WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SECS WEB SITE AT HTTP://WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT
CHARGE, WHEN AVAILABLE, UPON REQUEST. REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS PROXY SOLICITOR, THE IDENTITY AND CONTACT INFORMATION FOR WHICH WILL BE SET FORTH IN THE PROXY STATEMENT THAT WILL BE MADE AVAILABLE TO
SHAREHOLDERS.
The participants in the proxy solicitation are anticipated to include Sarissa Capital, Sarissa Capital Offshore Master Fund LP
(Offshore), Sarissa Capital Master Fund II LP (Master II), Sarissa Capital Athena Offshore Fund Ltd (Athena), Sarissa Capital Catapult Fund LLC (Catapult), Sarissa Capital Hawkeye Fund LP
(Hawkeye), ISP Fund LP (ISP), Atom Master Fund LP (Atom), Sarissa Capital Management GP LLC (Management GP), Sarissa Capital Offshore Fund GP LLC (Offshore GP), Sarissa Capital Fund GP LP
(Fund GP LP), Sarissa Capital Fund GP LLC (Fund GP LLC), Dr. Alexander J. Denner, Patrice Bonfiglio, Dr. Paul Cohen, Mark DiPaolo, Keith L. Horn, Odysseas Kostas, Louis Sterling III and Diane E. Sullivan.
As of the date hereof and subject to the further explanatory information set forth in this paragraph, funds and other investment vehicles affiliated with
Sarissa Capital and Dr. Denner may be deemed to beneficially own, within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act), 25,210,000 ordinary
shares, par value 50 pence per share, of the Company (the Shares), as more fully described below. In addition, as of the date hereof, Mr. Sterling may be deemed to separately beneficially own, within the meaning of Rule 13d-3 under the Exchange Act, 117,772 Shares. Given Mr. Sterlings beneficial ownership of Shares, he and the funds and other investment vehicles affiliated with Sarissa Capital and Dr. Denner may be
deemed to have formed a group within the meaning of Rule 13d-5(b) under the Exchange Act. The number of Shares stated herein that may be deemed to be beneficially owned by Mr. Sterling does not include
Shares that may be deemed to be beneficially owned by such funds and other investment vehicles, and the number of Shares stated herein that may be deemed to be beneficially owned by such funds and other investment vehicles does not include Shares
that may be deemed to be beneficially owned by Mr. Sterling. Subject to the preceding sentence, as of the date hereof, the number of Shares that may be deemed to be beneficially owned, within the meaning of Rule
13d-3 under the Exchange Act, by funds and other investment vehicles affiliated with Sarissa Capital and Dr. Denner is as follows:
|
|
|
|
|
Sarissa Capital |
|
|
25,210,000 |
|
Offshore |
|
|
6,188,100 |
|
Master II |
|
|
342,600 |
|
Athena |
|
|
3,164,000 |
|
Catapult |
|
|
4,298,200 |
|
Hawkeye |
|
|
3,928,800 |
|
ISP |
|
|
6,663,377 |
|
Atom |
|
|
624,923 |
|
Management GP |
|
|
25,210,000 |
|
Offshore GP |
|
|
9,694,700 |
|
Fund GP LP |
|
|
17,921,700 |
|
Fund GP LLC |
|
|
17,921,700 |
|
Dr. Denner |
|
|
25,210,000 |
|